Table 6. Treatment timing and hearing recovery rate.
Timing (days)* | No. of cases | Recovery rate (%) | Hearing level at initial exam (dB) |
0 | 28 | 63.6% | 78.69 |
1 | 55 | 70.1% | 69.49 |
2 | 40 | 65.4% | 67.33 |
3 | 35 | 68.7% | 63.26 |
4 | 16 | 49.9% | 69.81 |
5 | 12 | 56.9% | 61.25 |
6 | 11 | 34.5% | 60.45 |
7 | 6 | 59.5% | 57.83 |
APTT, activated partial thromboplastin time; ESR, erythrocyte sedimentation rate; FBS, fasting blood sugar; FDP, fibrinogen degradation products; Hct, hematocrit; HgbA1c, hemoglobin A1c; LDL, low-density lipoprotein cholesterol; Plt, platelets; PT, prothrombin time; RBC, red blood cell count; TG, triglycerides; WBC, white blood cell count.
*Initiation of treatment relative to ISSNHL onset; zero day is baseline value.